Mattia Capulli

Dante Labs International LLC engages in provision of genomic tests. The company was founded on May 3, 2017 and is headquartered in New York, NY.

GRAIL, Inc. is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

BlueGnome Ltd. provides application software services. It offers solutions for detection of copy number variation in the human genome. The firm's main application areas include analysis of constitutional samples to elucidate genetic disease, investigation of haematological malignancies and aneuploidy screening of single cells. The company was founded on October 15, 2001 and is headquartered in Saffron Walden, the United Kingdom.

Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom.

Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom.

Arrogene, Inc. commercializes a cancer treatment technology and a proprietary molecular delivery platform. Its technology delivers peptide, protein and oligonucleotide therapeutics across the blood-brain barrier to cancer cells to prevent tumor growth or for imaging. The company was founded by Julia Ljubimova, Alexander Ljubimova, Keith Black and Eggehard Holler in 2006 and is headquartered in Los Angeles, CA.

Foresight Diagnostics, Inc. is a privately held cancer diagnostics company based in Aurora, CO. The company has developed a liquid biopsy testing platform for the measurement of minimal residual disease (MRD) that is significantly more sensitive than existing tests, with a detection limit below 0.0001% or one part-per-million. This improved sensitivity provides actionable information to physicians and biopharmaceutical companies to enable more personalized treatment approaches for patients with a variety of cancers. The company's experts specialize in liquid biopsy and cancer genomics, developing an MRD assay centered on the detection of ctdna via phased variant sequencing. The company uses phased-seq® liquid biopsy technology for cancer relapse surveillance by monitoring cfdna/ctdna in the blood of lymphoma and lung cancer patients. The company was founded by Maximilian Diehn, Ash Alizadeh, Jake Chabon, and David Kurtz, with Jake Chabon serving as the CEO since incorporation.

ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO.

Pedago LLC provides revolutionizes online education services. The company was founded by Tom Adams and is headquartered in Washington, DC.

Kindred Capital LLP (Kindred Capital) is a venture capital firm founded in 2015. The firm is headquartered in London, UK.

Dante Labs Srl provides genetic testing laboratory services. The firm offers sequencing-based genetic tests, including hereditary cancer and cardiovascular disease risk assessment tests directly to consumers in Europe. It has offices in Italy and New York. The company was founded by Mattia Capulli and Andrea Riposati in 2016 and is headquartered in Pizzoli, Italy.

Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California.

Cambridge Cancer Genomics Ltd. provide cancer therapy. It also provides health care and diagnostics. The company is headquartered in Cambridge, the United Kingdom.

Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million.

Part of Illumina, Inc., Illumina GmbH is a German company that sells medical laboratory equipment. The company is based in Berlin, Germany. The CEOs are Nicola Letha Cranfield and Norbert Maria Hubert Keller. The company was founded in 2002.

Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million.

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

Angle Health, Inc. operates as a health insurance carrier. Its health insurance plans focuses on startup companies. The company was founded by Tylon Wang and Anirban Gangopadhyay in 2019 and is headquartered in San Francisco, CA.